Comparison of international blood pressure guidelines

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Ewingdo (talk | contribs) at 21:03, 24 March 2024 (Added ACC/AHA Guidelines). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Guidelines on the choice of agents and how best to step up treatment for various subgroups have changed over time and differ between countries.

A Comparison of International Guidelines on Goal BP and Initial Drug Therapy for Adults With Hypertension (modified from[1])
Guideline Population Goal BP, mmHg Initial drug treatment options
AAFP

2022[2][3]

General - Strong Recommendation

General - Weak Recommendation

<140/90

<135/85

Stage 1 >140/90 and low-risk for ASCVD: Lifestyle changes

Stage 1 >140/90 and ASCVD risk factors or failed lifestyle changes: monotherapy with thiazide-type diuretic, ACEI, ARB, or CCB

Stage 1 > 160/100: two from different classes - thiazide-type diuretic, ACEI, ARB, or CCB

ACC/AHA 2017[4] General <130/80 BP > 130/80: Lifestyle changes and monotherapy with thiazide-type diuretic, ACEI, ARB, or CCB

BP >20//10 above target: Lifestyle changes and two from different classes - thiazide-type diuretic, ACEI, ARB, or CCB

JNC8[1] General ≥60 y

General <60 y

Diabetes

CKD

<150/90

<140/90

<140/90

<140/90

Non-black: thiazide-type diuretic, ACEI, ARB, or CCB

Black: thiazide-type diuretic, or CCB

Diabetes: thiazide-type diuretic, ACEI, ARB, or CCB

CKD: ACEI or ARB

ESH/ESC 2008 General nonelderly

General elderly

General ≥80 y

Diabetes

CKD

CKD + proteinuria

<140/90

<150/90

<150/90

<140/85

<140/90

<130/90

General: beta-blocker, diuretic, CCB, ACEI, or ARB

Diabetes: ACEI, or ARB

CKD: ACEI, or ARB

CHEP 2013 General <80 y

General ≥80 y

Diabetes

CKD

<140/90

<150/90

<130/80

<140/90

General: thiazide-type diuretic, beta-blocker (age, 60 y), ACEI (non-black) or ARB

Diabetes with additional risk : ACEI, or ARB

Diabetes without additional risk : ACEI, ARB, thiazide, or DHPCCB

CKD: ACEI, or ARB

ADA 2013 Diabetes <140/90 ACEI, or ARB
KDIGO CKD no proteinuria

CKD + proteinuria

≤140/90

≤130/80

ACEI, or ARB
NICE 2011 General <80 y

General ≥80 y

<140/90

<150/90

<55 y: ACEI, or ARB

≥55 y or black: CCB

ISHIB Black, lower risk

Target organ damage or CVD risk

<135/85

<130/80

Diuretic or CCB

Abbreviations:

  • ACC – American College of Cardiology
  • ACEI – angiotensin-converting enzyme inhibitor
  • ADA – American Diabetes Association
  • AHA – American Heart Association
  • ARB – angiotensin receptor
  • CCB – calcium channel blocker
  • CHEP – Canadian Hypertension Education Program
  • CKD – chronic kidney disease
  • CVD – cardiovascular disease
  • DHPCCB – dihydropyridine calcium channel blocker
  • ESC – European Society of Cardiology
  • ESH – European Society of Hypertension
  • ISHIB – International Society for Hypertension in Blacks
  • JNC – Joint National Committee
  • KDIGO – Kidney Disease: Improving Global Outcome
  • NICE – National Institute for Health and Clinical Excellence


References

  1. ^ a b James, PA.; Oparil, S.; Carter, BL.; Cushman, WC.; Dennison-Himmelfarb, C.; Handler, J.; Lackland, DT.; Lefevre, ML.; Mackenzie, TD.; Ogedegbe, Olugbenga; Smith, Sidney C.; Svetkey, Laura P.; Taler, Sandra J.; Townsend, Raymond R.; Wright, Jackson T.; Narva, Andrew S.; Ortiz, Eduardo (Dec 2013). "2014 Evidence-Based Guideline for the Management of High Blood Pressure in Adults: Report From the Panel Members Appointed to the Eighth Joint National Committee (JNC 8)". JAMA. 311 (5): 507–20. doi:10.1001/jama.2013.284427. PMID 24352797.
  2. ^ Coles, Sarah; Fisher, Lynn; Lin, Kenneth W.; Lyon, Corey; Vosooney, Alexis A.; Bird, Melanie D. (2022-12). "Blood Pressure Targets in Adults With Hypertension: A Clinical Practice Guideline From the AAFP". American Family Physician. 106 (6): Online. ISSN 1532-0650. PMID 36521481. {{cite journal}}: Check date values in: |date= (help)
  3. ^ Clarke, S. Lindsey (2023-10). "Hypertension in Adults: Initial Evaluation and Management". American Family Physician. 108 (4): 352–359. ISSN 1532-0650. PMID 37843942. {{cite journal}}: Check date values in: |date= (help)
  4. ^ Whelton, Paul K.; Carey, Robert M.; Aronow, Wilbert S.; Casey, Donald E.; Collins, Karen J.; Dennison Himmelfarb, Cheryl; DePalma, Sondra M.; Gidding, Samuel; Jamerson, Kenneth A.; Jones, Daniel W.; MacLaughlin, Eric J.; Muntner, Paul; Ovbiagele, Bruce; Smith, Sidney C.; Spencer, Crystal C. (2018-05). "2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults". Journal of the American College of Cardiology. 71 (19): e127–e248. doi:10.1016/j.jacc.2017.11.006. {{cite journal}}: Check date values in: |date= (help)